New CLIA-Waived Tests

Providers can now bill for six new tests (4 drug tests and two lipid/glucose panels) that have been approved by the FDA as waived tests under CLIA. CLIA-waived tests are simple tests performed at the point-of-care using devices that are largely exempt from federal requirements, including most training, proficiency testing, and quality control regulations (unless specified as required in the test system instructions).  In order to be reimbursed for these tests, sites must hold the appropriate CLIA certificate and include their certificate number when submitting test claims. The CPT® codes, effective date, and description for each new test are provided below. Except for procedure 82962, all of the new CLIA-waived tests must have modifier QW added in order to be recognized as a waived test.

 

CPT® Code Effective Date Test Description
G0434QW

 

May 29, 2013

 

SCI International Inc. New Choice At Home Drug Test:

Marijuana (Strip Format)

82465QW

83718QW

84478QW

82962

July 1, 2013 Infopia USA, LipidPro® Professional Lipid Profile and Glucose

Measuring System

G0434QW July 29, 2013 Alere iCup DX 14 (Cassette Dip Card format)
G0434QW September 25, 2013 American Screening Corporation, Inc. Discover Drug Test

Cards

G0434QW September 25, 2013 American Screening Corporation, Inc. Discover Multi-Panel

Drug Test Cups

82465QW

83718QW

84478QW

82962

November 12, 2013 Jant Pharmacal Corp, LipidPlus Professional Lipid Profile and

Glucose Measuring System

 

Author: Codapedia Staff

– Source: http://codapedia.com/article_672_New-CLIA-Waived-Tests.cfm#sthash.iMpf5SlG.dpuf

Leave a Reply